2013 Fiscal Year Final Research Report
Development of novel anti-tumor drugs inhibiting Anamorsin and Picot binding
Project/Area Number |
23591387
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Osaka University |
Principal Investigator |
SAITOH Norimitsu 大阪大学, 大学院医学(系)研究科(研究院), 特任助教(常勤) (30597399)
|
Co-Investigator(Kenkyū-buntansha) |
SHIBAYAMA Hirohiko 大阪大学, 大学院医学系研究科, 講師 (60346202)
KANAKURA Yuzuru 大阪大学, 大学院医学系研究科, 教授 (20177489)
ORITANI Kenji 大阪大学, 大学院医学系研究科, 准教授 (70324762)
|
Project Period (FY) |
2011 – 2013
|
Keywords | Anamorsin / Picot / 鉄硫黄クラスター / 細胞内シグナル伝達 / Ras / Bリンパ球 / LPS / B細胞性リンパ腫 |
Research Abstract |
Anamorsin (AM) was originally isolated as a molecule that conferred resistance to apoptosis. AM deficient mice die during late gestation; AM is indispensable for embryo growth and hematopoiesis. Furthermore, our previous study showed AM overexpression in approximately 30% of B cell neoplasm cases. In this work, we focused on B cells of AM transgenic (Tg) mice. LPS-stimulated proliferation of AM Tg B cells was decreased compared with WT mice. Phosphorylation of Erk1/2 and IKBa in LPS-stimulated AM Tg B cells was also decreased. Upstream analysis based on the results of DNA micro array comparing AM Tg and WT B cells stimulated with or without LPS suggested that Ras activation was decreased in LPS-stimulated AM Tg B cells. We also confirmed impairment of LPS induced Ras activation in AM Tg mice by Ras assay. Our findings indicate the possibility that AM plays a role of negative regulation in LPS signaling pathway through the inhibition of Ras activation, which is a novel function of AM.
|
Research Products
(19 results)